Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes.
Cai EP, Ishikawa Y, Zhang W, Leite NC, Li J, Hou S, Kiaf B, Hollister-Lock J, Yilmaz NK, Schiffer CA, Melton DA, Kissler S, Yi P.
Cai EP, et al. Among authors: yilmaz nk.
Nat Metab. 2020 Sep;2(9):934-945. doi: 10.1038/s42255-020-0254-1. Epub 2020 Jul 27.
Nat Metab. 2020.
PMID: 32719542
Free PMC article.